We are studying the effects of two medications on patients with advanced dedifferentiated liposarcoma. The goal is to see if they improve treatment outcomes and quality of life.
Health conditions and diseases that the clinical trial is designed to study and treat.
Dedifferentiated Liposarcoma is a rare type of cancer that arises from fat cells and can occur in various parts of the body. It is characterized by the presence of both well-differentiated and poorly differentiated tumor cells, which can lead to aggressive behavior and metastasis.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
